NewAmsterdam Pharma Co NV (NAS:NAMS)
$ 27.96 +0.29 (+1.05%) Market Cap: 3.34 Bil Enterprise Value: 2.71 Bil PE Ratio: 0 PB Ratio: 5.21 GF Score: 45/100

NewAmsterdam Pharma Company NV at Bank of America Global Healthcare Conference Transcript

May 12, 2026 / 12:15 AM GMT
Release Date Price: $37.75 (-2.93%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

NAMS.OQ - NewAmsterdam Pharma Company NV
NewAmsterdam Pharma Company NV at Bank of America Global Healthcare Conference
May 13, 2026 / 12:15AM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Bank of America Healthcare Conference in extremely toasty Las Vegas.

Ending up our final talk of the day is, I'm very pleased to have join us, the team from New Amsterdam.

So this is Ian Somia and BJ Jones, Chief Commercial Officer. Gentlemen, thank you so much for joining us. Pleasure.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Yeah, thanks for the invite.

--------------------------------------------------------------------------------
Unidentified_1 [3]
--------------------------------------
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot